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Background: Efforts to control malaria are demanding due to drug-resistant parasites, insecticide-resistant
mosquitoes and poor health infrastructure in malaria-endemic countries. Therefore, the research and development
of additional malaria control methods are crucial. For host-parasite interactions, surface antigens and secreted
proteins are likely to be involved in infectivity and invasion of host tissues and therefore can be effective targets for
control by vaccines, drug therapy, or novel mosquito control methods. In an effort to identify and characterize
genes that may have a role in host-parasite interaction, this study describes the expression profile of Plasmodium
falciparum PF3D7_1363700.
Methods: A P. falciparum gene, PF3D7_1363700, was identified by a search of the annotated Plasmodium genome
database. Protein alignments of PF3D7_1363700 orthologues from various Plasmodium species were performed to
demonstrate protein similarity. Transcript expression profiles of PF3D7_1363700 were determined via reverse-
transcriptase PCR and protein expression was investigated by immunofluorescence assays, western blot analysis and
green fluorescent trafficking studies.
Results: The PF3D7_1363700 protein demonstrates significant similarity with orthologues in other Plasmodium
species and appears to be unique to Apicomplexans. The PF3D7_1363700 transcription profile demonstrated
expression during the intra-erythrocytic, oocyst sporozoite, and salivary gland sporozoite stages while the
PF3D7_1363700 protein was only detected during the intra-erythrocytic stages.
Conclusions: This research utilized an in silico approach to identify a well-conserved protein known as
PF3D7_1363700. By molecular, biochemical and cellular analyses, PF3D7_1363700 was discovered to be an intra-
erythrocytic-specific stage protein that is unique to Apicomplexans.
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Malaria is a mosquito-borne disease responsible for ap-
proximately 216 million human infections and an
estimated 655,000 deaths annually, with most deaths oc-
curring in African children [1]. Novel therapeutic inter-
vention methods and other ways to complement or
replace existing malaria control methods are a necessity
to combat malaria especially when drug-resistant
parasites and mosquitoes resistant to commonly used
insecticides are a continuing issue and there is no* Correspondence: BeerntsenB@missouri.edu
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reproduction in any medium, provided the oreffective malaria vaccine available [2-5]. New bio-
informatics analyses of the Plasmodium genome and
proteome have provided opportunities to identify and
search for protein candidates that potentially can serve
as effective targets for vaccines, drug therapy, and/or
novel mosquito control methods.
In an effort to discover new anti-malarial targets, data
mining of the Plasmodium genome database (PlasmoDB;
[6]) was performed to specifically select Plasmodium
proteins expressed on the surface of the malaria parasite,
which are often ideal targets. As a result, a novel
Plasmodium falciparum gene, PF3D7_1363700, also pre-
viously known as PfMAL13P1.319, was identified as a
2.3-kb gene that encodes a 790-amino acid protein.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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PF3D7_1363700 as a sporozoite surface protein via pro-
tein mass spectrometry, the research described herein
analyzed PF3D7_1363700 via molecular, biochemical and
cellular assays and discovered that it is likely a secreted
protein expressed during the late intra-erythrocytic stages.
The PF3D7_1363700 protein has orthologues in various
Plasmodium species and appears to be unique to
Apicomplexans since no orthologues of PF3D7_1363700
were identified in higher eukaryotic organisms. Here, this
research investigated the transcript and protein expression
profile of PF3D7_1363700 in an effort to understand the
potential role of PF3D7_1363700 in malaria parasite
biology.
Methods
Mosquito and Plasmodium parasite maintenance and
transmission
Anopheles stephensi were reared as previously described
[7,8] and used for maintaining the P. falciparum life
cycle and parasite transmission. The P. falciparum NF54
strain and 3D7HT-GFP parasites (a constitutively green
fluorescent protein (GFP)-expressing parasite line) were
maintained according to a standard protocol [8,9] and
used for mosquito-parasite infections. Mosquito parasite
transmission studies also were performed according to
standard protocol [8]. Gametocyte cultures used for mos-
quito parasite transmission and for transcript and protein
analysis were established by maintaining a 0.5% parasit-
aemia NF54 culture supplemented with 10% human
serum (A+ male, Interstate Blood Bank) at a 3% haemato-
crit and changing medium every other day for 16 days
[10,11].
Enrichment of intra-erythrocytic stages was performed
by synchronizing parasites using 5% D-sorbitol (Sigma)
according to standard procedure [10]. Briefly, parasite-
infected cells were pelleted at 2,000 × g for 5 minutes and
resuspended with five pellet volumes of 5% D-sorbitol for
5 minutes at room temperature. Infected RBCs were
centrifuged again at 2,000 × g for 5 minutes and washed
three times with 10 pellet volumes of RPMI 1640. After
removal of the final wash, parasite-infected RBCs were
resuspended in culture medium, gassed with a 3% O2, 3%
CO2 and 94% N2 gas mixture and incubated at 37°C.
All experiments described herein were approved by and
performed in accordance with the Institutional Biosafety
Committee (IBC), the Institutional Review Board (IRB),
and the University of Missouri Institutional Animal Care
and Use Committee (IACUC).
Plasmodium falciparum parasite isolation
Sporozoite isolation
To obtain P. falciparum oocyst and salivary gland sporo-
zoite stages, 3–7 day old mosquitoes maintained usingconditions reported previously were exposed to an
infected bloodmeal and dissected 8–10 days post-
exposure (PE) for P. falciparum oocyst sporozoites and
14–21 days PE for P. falciparum salivary gland
sporozoites. Isolation of oocyst sporozoites was performed
by removing the mosquito midgut, transferring it to a
slide with a drop of 1X PBS (137mM NaCl, 2.7 mM KCl,
10mM Na2HPO4, and 2mM KH2PO4), then rupturing
the midgut oocysts by placing a coverslip onto the midgut
to release mature sporozoites from the oocysts. Plasmo-
dium salivary gland sporozoites were isolated by dissecting
the infected salivary glands and placing them in a tube of
50 μl 1X PBS where sporozoites were released from the
salivary glands by vigorous pipetting and processed as pre-
viously described [7].
Axenic liver stage isolation
Plasmodium falciparum axenic liver stage parasites were
obtained in the absence of host hepatocytes as previ-
ously described [8,12].
Obtaining parasite lysates for DNA and protein analysis
To obtain oocyst and salivary gland sporozoite lysates,
sporozoites isolated from oocysts (n = ~100 mosquitoes)
or salivary glands (n=~100 mosquitoes) were either homo-
genized and used for RNA isolation or resuspended with
1X reducing buffer (0.5% bromophenol blue, 4% SDS, 10%
2-β-mercaptoethanol) for protein analysis. In order to pre-
pare erythrocytic stage parasite lysates (i.e., a mixture of
rings, trophozoites, schizonts and gametocytes), infected
blood was centrifuged at 2,700 × g for 5 minutes and the
supernatant discarded. The pellet was resuspended in a
solution containing 0.05% (w/v) saponin (Sigma) in RPMI
1640 medium and incubated for 2 minutes at room
temperature in order to lyse the RBCs and release
parasites. Saponin-treated cells were pelleted at 2,700 × g
for 10 minutes and washed at least twice with RPMI 1640
medium. The resulting pellet either was resuspended in
1X PBS for genomic DNA isolation (Qiagen DNeasy
Blood and Tissue Kit), 1X reducing buffer for protein ana-
lysis or TRIzol reagent (Invitrogen) for RNA isolation.
Identification and sequence analysis of PF3D7_1363700
Initial efforts to identify novel sporozoite surface or
secreted proteins that may be involved in sporozoite in-
vasion of host tissues were performed by data mining
PlasmoDB [6]. The data-mining search specifically aimed
to select for uncharacterized genes that expressed protein
during the sporozoite stage, although future analyses
suggested otherwise, and was predicted to be a surface or
secreted protein with a signal peptide. The PF3D7_1363700
protein was identified and protein sequences were
subjected to BLAST analysis within PlasmoDB [6] and Na-
tional Center for Biotechnology Information (NCBI) [13]
Roberts et al. Malaria Journal 2013, 12:66 Page 3 of 14
http://www.malariajournal.com/content/12/1/66databases to determine protein similarity. Additional ana-
lyses were obtained using Expert Protein Analysis System
(ExPASy) proteomic tools such as TargetP and SignalP for
signal peptide/anchor predictions, PSORTII, TMAP, and
DGPI for localization, transmembrane and GPI anchor
predictions, and Pfam and Prosite for classifying family
proteins and identifying functional sites, and other
patterns/profiles [14].Reverse-transcription PCR (RT-PCR) and PCR analysis
To examine the expression of PF3D7_1363700 in oocyst
sporozoites, salivary gland sporozoites, axenic liver sta-
ges and intra-erythrocytic stages, total RNA was isolated
using the TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions. Total RNA was DNase
treated (Ambion) to remove residual genomic DNA and
2–3 μg of RNA was used as a template for Superscript™
First-Strand Synthesis System Reverse Transcriptase-
Polymerase Chain Reaction (RT-PCR; Invitrogen) to make
first-strand cDNA. PCR amplification of the cDNA was
performed with gene specific forward (F) and reverse (R)
primers, PF3D7_1363700- F: 50-GAGCACATCGATGG
GGAGG-30 and R: 50-TTAACTTGAGTCTAGACCTCTG
G-30; Plasmodium falciparum merozoite surface protein
(PfMSP-1) - F: 50-AAACTAGAAGCTTTAGAAGATGCA
G-30 and R: 50-CCCTTCTTCATTATCTGCATTCTT-30;
Plasmodium falciparum sexual-stage antigen (Pfs230) - F:
50-TATAACGCTGAAGAATCTATTCCTC-30 and R: 50-
GTACTAGGTTAAAGCTATCCGAGG-30; P. falciparum
circumsporozoite (PfCS) - F: 50-CGCGGATCCATGATGA
GAAAATTAGCTAT-30 and R: 50-CCGCTCGAGCTAAT
TAAGGAACAAGAAG-30 and P. falciparum heat shock
protein 70 (PfHSP70) - F: 50-AGGTATAGAAACTGTGG
GTGG-30 and R: 50-GATTGGTTGGCATACAGCTTC-30
control gene primers were used to detect asexual blood
stage, gametocyte, sporozoite, and liver stage transcripts,
respectively. Plasmodium falciparum NF54 genomic DNA
was used as a positive control template and a no reverse-
transcriptase cDNA was utilized to control for genomic
DNA contamination.
PCR amplifications were carried out using the
following conditions: 1.5 mM MgCl2, 0.2 mM dNTP, 2.5
U Taq polymerase (Promega), 0.4 mM of each primer,
and ~100 ng of cDNA template to a total reaction vol-
ume of 50 μl. PCR amplification was performed as
follows: 1) initial denaturation at 94°C for 5 minutes; 2)
denaturation at 94°C for 30 seconds; 3) annealing at
50°C for 45 seconds; 4) extension at 62°C for 2 minutes
and 5) final extension at 62°C for 10 minutes. Each
amplification cycle was repeated 34 times. Resulting
products were separated via 1% agarose gel electro-
phoresis and stained with ethidium bromide for
visualization.Generating anti-PF3D7_1363700 antibodies
To produce antibodies for immunocytochemistry studies,
the signal peptide region was omitted and the remaining
PF3D7_1363700 genewas divided into thirds (i.e., fragments
A-C)duetotherelatively largesizeof thegeneanddifficulties
when producing the entire protein. The N-terminal A frag-
ment of PF3D7_1363700 (PF3D7_1363700-A) was chosen
for commercial antibody production so that the truncated-
protein produced fromany gene-disruptedmutant parasites
could be detected. First, PCR amplification was performed
using gene specific forward and reverse primers for this
region (BamHI and NotI restriction enzyme sites are
italicized):
Fragment A: F: 50-CGGGATCCTTGATCATAAAATA
TAATGTCAAG-30 and R: 50-AGTGCGGCCGCTTATCC
TATTTCATGTAATAACAAA-30. Then, this fragment
was cloned into the pCRWII-TOPOW vector (Invitrogen),
sequenced, double-digested and cloned into the pET-32a
expression vector (Novagen). Recombinant DNA plasmids
were transformed into Rosetti-gami cells (Novagen) and
the cells were induced with 1 mM IPTG. Inclusion bodies
and soluble fractions were obtained by sonicating
harvested cells with 10-second bursts at a medium inten-
sity setting using the Sonic Dismembrator (Fisher Scien-
tific), freezing the lysate in liquid nitrogen for one minute,
and thawing the lysate in a 42°C water bath. This rapid
freeze thaw-sonication procedure was repeated at least
three times. Removal of soluble protein was obtained by
centrifugation at 25,000 × g for 20 minutes and the inclu-
sion bodies were used for antibody production since
PF3D7_1363700-A recombinant protein was present in
inclusion bodies via Western blot analysis. Commercial
rabbit polyclonal anti- PF3D7_1363700-A antibodies were
produced by Sigma Genosys. The first immunization
consisted of 200 μg of recombinant PF3D7_1363700-A
mixed with Freund’s Complete Adjuvant while subsequent
immunizations (i.e., a total of five injections) used 100 μg
of PF3D7_1363700-A plus Incomplete Freund’s adjuvant.
Recovered antibodies were titrated and tested for recom-
binant PF3D7_1363700-A detection. Pre-immune serum
also was obtained before immunizations.
Polyclonal anti- PF3D7_1363700 antibodies and pre-
immune serum were IgG-purified using the Melon Gel
IgG Purification Kit (Pierce). To further purify anti-
bodies to reduce cross-reaction against tissues and pET-
32a bacterial protein lysate, two purification methods
were performed for either Western blot analysis or im-
munofluorescent assays (IFA). For antibodies used in
Western blot analyses, anti-PF3D7_1363700 antibodies
were purified as previously described by Schlarman and
colleagues [8]. Antibodies for IFA were purified using a
pre-absorption method as previously described [7],
which consisted of pre-absorbing the antibodies against
protein lysates of mosquito midguts, mosquito salivary
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lysates. Briefly, protein lysates from mosquito midguts or
salivary glands were made by homogenizing mosquito
midguts (n = 10) or salivary glands (n = 20) in 1X PBS,
respectively, while protein lysates from RBCs were
obtained by saponin-treatment. All lysates were
resuspended in reducing sample buffer, denatured at
95°C for 10 minutes and separated on a short, 10% SDS-
PAGE mini-gel (approximately 2.5 cm). Proteins were
transferred to nitrocellulose and each lane was cut into
nitrocellulose strips and individually incubated with
diluted anti-PF3D7_1363700 antibodies or pre-immune
serum. Anti-PF3D7_1363700 antibodies and pre-immune
sera were each incubated with three strips of proteins
from midguts, salivary glands, RBCs, and pET-32a protein
lysates.
Western blot analysis
Erythrocytic stage parasite lysates (including mutant
PF3D7_1363700-green fluorescent protein (GFP) lysates)
were prepared by saponin-treating parasite-infected RBCs
and resuspending the pellet with a 1:1 dilution of 1X redu-
cing buffer and 1X PBS. Lysates were separated on a 10 or
12% SDS-PAGE gel and transferred onto a nitroceullose
membrane. Membranes were blocked with 5% non-fat dry
milk-Tris buffered saline (TBS; 0.15M NaCl, 50mM Tris)
for approximately 1 hour at room temperature, washed
three times in 1X TBS, then incubated with a 1:100 dilu-
tion of purified pre-immune serum (i.e., used a negative
control to show no cross-reacting antibodies), rabbit-anti
-PF3D7_1363700 antibodies, or anti-GFP in TBST (TBS/
0.05% Tween 20) overnight at 4°C on a shaker. After over-
night incubation, the membrane was washed three times
with 1X TBST, and incubated with a 1:20,000 dilution of
secondary antibody (i.e., peroxidase-conjugated anti-rabbit
IgG or anti-mouse IgG; Sigma) and visualized using an
enhanced chemiluminescence (ECL) detection system
(Amersham Biosciences). There were three biological
replicates performed for Western blot analyses.
Immunofluorescence assay (IFA) and confocal microscopy
For immunofluorescence analysis of the PF3D7_1363700
protein during the intra-erythrocytic stages, parasite-
infected blood smears (the same parasites were used for
transcriptional analysis) of mixed intra-erythrocytic
stages or mixed gametocyte stages were made on glass
slides, fixed with 100% ice-cold methanol and 100%
acetone at −20°C, washed three times with 1X PBS and
blocked with 1X PBS/10% foetal bovine serum (FBS) for
4 hours. Slides were then incubated with either pre-
absorbed control pre-immune serum or pre-absorbed
anti-PF3D7_1363700 antibodies in 1X PBS/10% FBS
(1:50) overnight at 4°C. Smears were washed three times
with 1X PBS then incubated with control primaryantibodies (1:200) (i.e., antimerozoite surface protein 1
(MSP1; MRA-94; MR4 ATCC) monoclonal antibodies for
asexual stages or anti-Pfs230 (MRA-27; MR4 ATCC)
monoclonal antibodies for gametocytes). Lastly, smears
were washed with 1X PBS and double-labelled with TO-
PRO-3 nuclear stain (1:50) (Molecular Probes) and sec-
ondary antibodies Alexa-488 and −586 (1:200) (Molecular
Probes) for 2 hours at room temperature. After three
washes, one drop of ProLongW Gold (Invitrogen) antifade
reagent was added to the slide followed by a coverslip.
Parasites were analysed using a Zeiss Laser Scanning
Microscope (LSM) 510 META NLO two-photon point-
scanning confocal microscope with a 100X oil immersion
objective. An estimated 300 parasites were examined for
each of the three biological replicates of mixed erythro-
cytic stages, while approximately 100 gametocytes (i.e., a
mixture of I-V gametocyte stages) were examined for each
of the two biological replicates.
Oocyst and salivary gland sporozoite slides were made
as previously described [8,15]. Pre-absorbed pre-immune
or anti-PF3D7_1363700 antibodies were diluted (1:25) in
1% goat serum plus 1% bovine serum albumin (BSA)
and a volume of 40–100 μl were incubated on the slides
overnight at 4°C. A 1:200 dilution of control primary anti-
body, anti-circumsporozoite protein (CS) MAb (MRA-
183; MR4 ATCC) also incubated on the slides. Two
biological replicates of oocyst sporozoites were performed
and 150 oocyst sporozoites/replicate were counted and
analysed for PF3D7_1363700 expression. At least two bio-
logical replicates of salivary gland sporozoites at days 14,
15, 16 and 20 PE were performed with 100–150
sporozoites/day/replicate observed. Additionally, one bio-
logical replicate of sporozoites at days 17, 18, 19, and 21
PE with a minimum of 20 sporozoites for each time point
were observed.PF3D7_1363700-GFP construct design
PF3D7_1363700 was PCR-amplified from a NF54 para-
site strain genomic DNA template using forward primer
and reverse primers, F: 50-CCGCTCGAGGGAGCACA
TCGATGGGGAG-30 and R: 50-CCTAGGACTTGAGT
CTAGACCTCTGGA-30 (XhoI and AvrII restriction en-
zymes are italicized). The resulting product was cloned
into the pPM2GT vector [16] to generate the plasmid
designated as MpPM2GT. The schematic and standard
protocol were previously described by Schlarman and
colleagues, with the exception that the PF3D7_1363700
product was ligated into the pPM2GT vector [8]. GFP
expression was controlled by the endogenous promoter
of PF3D7_1363700 and parasites with the vector were
selected using the drug-resistance cassette containing
human dihydrofolate reductase (DHFR) sequence [8,17].
This MpPM2GT plasmid was sequenced to verify
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in frame, thereby allowing expression of GFP.
Isolating clonal populations of PF3D7_1363700-GFP
parasites and genotype analysis via PCR and Southern
blot analysis
In order to transfect MpPM2GT into NF54 parasites,
sorbitol-synchronized ring stage parasites at a 2-3%
parasitaemia were electroporated with 50–100 μg of
MpPM2GT plasmid DNA using low voltage conditions
(BTX 600; 0.2 cm cuvette, 0.31 kV, 950 μF) [10,18]. Selec-
tion for parasites with plasmid integration into the gen-
ome (integrants) or parasites carrying episome was
performed using 5 nM WR99210 (Jacobus Pharmaceutical
Company Inc.) with three drug selection cycles (i.e., each
WR99210 drug cycle = 4–6 weeks with drug and 3–4 -
weeks of drug removal) in order to enrich for integrants.
To assess the genotype of the parasite and detect if the
parasites had successfully integrated the construct, a PCR
analysis was performed using:
Wild-type control primers-F: 50-CCGCTCGAGGGAG
CACATCGATGGGGAG-30 and R: 50-CCTAGGACTTG
AGTCTAGACCTCTGGA-30; Episome control primers
(hDHFR drug cassette) - F: 50-ATGGTTGGTTCGCTA
AACTGC-30 and R: 50-TTAATCATTCTTCTCATATA
CTTC-30; Integration primers-F: 50-TGATAAAAATGG
ACAAACAGGG-30 and R: 50-TCCGTATGTTGCATCA
CC-30. PCR conditions were performed using the same
conditions described earlier, however in a 20 μl reaction
volume.
To further confirm the genotype, Southern blot ana-
lyses were done using 3–5 μg of DNA (i.e., either from
P. falciparum NF54 genomic DNA, MpPM2GT plasmid
DNA or MpPM2GT parasite culture DNA) that was
digested with 20 units of AleI and BamHI restriction
enzymes for 4 hours in a 37°C water bath. Digested
DNA was separated on a 0.8% electrophoretic agarose
gel and transferred to a nylon membrane (Osmonics).
Membranes were UV crosslinked and prehybridized at
65°C in Church buffer (0.17% Phosphoric acid, 1% BSA,
1 mM EDTA, 7% SDS, 3.5% sodium phosphate dibasic)
for 2 hours. After prehybridization, the membrane was
hybridized with PF3D7_1363700-specific probes which
were amplified using gene primer sets (F: 50-CCGCTCGA
GGGAGCACATCGATGGGGAG-30 and R: 50-CCTAGG
ACTTGAGTCTAGACCTCTGGA-30) and digoxigenin
(DIG; Roche Applied Science)-labelled.
Membrane and probe incubations were performed at
50°C in Church buffer overnight and washed twice with
2X SSC (3M sodium chloride, 0.3M sodium citrate,
pH 7.0) containing 0.1% sodium dodecyl sulphate (SDS)
at room temperature for 5 minutes and twice with 0.5X
SSC containing 0.1% SDS at 65°C for 15 minutes. De-
tection of DNA was achieved using the DIG Kit (RocheApplied Science) according to the manufacturer’s
instructions. CSPD disodium 3-(4-methoxyspiro {1,2-
dioxetane-3,20-(50-chloro)tricyclo [3.3.1.13,7]decan}-4-yl)
phenyl phosphate (Roche Applied Science) was used for
chemiluminescence detection and membranes were
exposed to X-ray film. Clonal populations were obtained
by performing limiting dilutions [19]. Limiting dilutions
were done by diluting parasites with culture medium to
0.5 and/or 0.25 parasites/well in two 96-well plates (i.e.,
one parasite every other well or every fourth well, re-
spectively). Each well consisted of 200 μl of a 2.5% haem-
atocrit and plates were placed in a gassed (3% O2, 3% CO2
and 94% N2) sealed Modular Incubator Chamber (Billups-
Rothenberg Incorporated) at 37°C. To increase humidity,
a small tissue culture plate with RPMI 1640 medium was
placed inside the chamber. Chambers were gassed every
second day, while culture medium was changed once a
week with a fresh 0.4% haematocrit. On days 20–24, gen-
omic DNA was isolated from each well to determine if
clonal populations were present. Genomic DNA was
isolated by removing 150 μl of the parasite culture and in-
cubating the culture with 6% saponin (Sigma) for 5 -
minutes at room temperature. The 96-well plate
containing this mixture was centrifuged at 2,650 × g for
15 minutes and the pellet was washed once with 1X PBS.
Genomic DNA was extracted using 40 μl of down scale
prep buffer (DSP; 1 M Tris-CL pH 8.0, 1 M KCL and 1
MgCl2) with an incubation of 50°C for 30 minutes and
then 95°C for 10 minutes.
PCR was used to verify integration with the following
conditions: 1 mM MgCl2, 0.2 mM dNTP, 1.25 U Taq poly-
merase (Promega), 0.5 mM of each primer, and 4 μl of
gDNA isolated from the 96-well plate. PCR amplification
was performed as follows: 1) initial denaturation at 95°C
for 3 minutes; 2) denaturation at 94°C for 30 seconds; 3)
annealing at 50°C for 45 seconds; 4) extension at 62°C for
3 minutes and 5) final extension at 62°C for 10 minutes.
Each amplification cycle was repeated 34 times. Wells
containing parasites as determined via PCR were
expanded in 12-well plates at a 3% haematocrit in 2 ml of
culture medium. Once the parasitaemia increased to ap-
proximately 2%, half the culture was cryopreserved in
Glycerolyte 57 (Baxter) and stored in liquid nitrogen while
the other half was expanded into a T25 flask (Corning
Incorporated) at a 3% haematocrit in 10ml of culture
medium. Southern blot analysis as described previously
was performed to confirm MpPM2GTclones.
Fluorescence microscopy for GFP trafficking studies
Stable transgenic P. falciparum MpPM2GT parasite
cultures were sorbitol-synchronized to allow specific
intra-erythrocytic stage parasites to be analysed and
enriched gametocyte stages were established as previously
described. GFP trafficking studies were conducted as
Figure 1 (See legend on next page.)
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Figure 1 Alignment of the PF3D7_1363700 (PfMal) protein sequence with its orthologues. PF3D7_1363700 shares conserved regions
with P. berghei (PbMal orf= PbANKA_113970 in PlasmoDB), P. chabaudi (PcMal orf= PCHAS_113920 in PlasmoDB), P. gallinaceum (PgMal orf=
Pg_c000129384. Contig1-2-1079-2746), P. knowlesi (PkMal orf= PKH_110700 in Sanger Institute), P. vivax (PvMal= Pv115140), P. yoelii (PyMal orf=
chrPyl_00226-5-31074-29071 in PlasmoDB), and P. reichenowi (PrMal= reich142b09.plk, reich382d09.qlk, reich915f08.plk, reich838g12.plk in
PlasmoDB). Identical residues are shaded in yellow while similar amino acids are shown in blue. The sequence used for antibody production is
indicated by the black horizontal bar. The D-I-N-H repeat sequence is highlighted in red.
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used for the GFP trafficking studies were P. falciparum
NF54 wild-type parasites (negative control) and P. falcip-
arum 3D7HT-GFP parasites (positive control) [9]. There
were three independent biological replicates performed
for each of the seven parasite stages analysed. For each
biological replicate, the numbers for each stage analysed
were: 50–100 trophozoites/schizonts/gametocytes, 2–5
zygotes, 5–15 oocysts with sporozoites, 2 haemolymph
sporozoites [8,15], and ~20 salivary gland sporozoites for
each day between day 14–20 PE.
Results and discussion
Bioinformatic sequence analyses of PF3D7_1363700
As a result of the P. falciparum genome sequencing pro-
ject and large-scale microarray and proteomic studies,
there are new opportunities to discover novel drug and
vaccine candidates. Ideal targets to prevent malaria trans-
mission are often surface antigens and secreted proteins
involved in parasite invasion of the mosquito and human
hosts [20-22]. In an effort to discover molecules in-
volved in parasite invasion, the P. falciparum gene
PF3D7_1363700 (also known as PfMAL13P1.319 and re-
ferred in the figures and figure legends as PfMal or PfM
or M) was selected based on protein expression and signal
peptide and localization predictions via in silico screening
of PlasmoDB. PF3D7_1363700 is a 790-amino acid pro-
tein that encodes a 92.8-kDa protein including the signal
peptide and a 89.1-kDa protein without the signal peptide.
Signal peptide predictions, according to the SignalP and
TargetP programs, indicated that PF3D7_1363700 has a
signal peptide, and therefore should enter the se-
cretory pathway. In support of this prediction, Softberry
and PSORTII, two localization programs, predicted
PF3D7_1363700 to be either a secreted or plasma mem-
brane protein. Based on topology predictions, there is one
transmembrane domain located within the signal peptide
region, which would suggest that PF3D7_1363700 may be
a secreted protein once the signal peptide is cleaved. The
ScanProsite program identified many potential enzyme
modification sites such as amidation, N-glycosylation
and N-myristolation, which would suggest that the
PF3D7_1363700 protein may be processed.
A putative indole-3-glycerol phosphate synthase
(IGPS) domain was identified, according to analyses
available on PlasmoDB [6]. IGPS is an enzyme thatcatalyses the fourth step in the tryptophan biosynthetic
pathway (i.e., indole ring-closure reaction) where the
substrate 1-(o-carboxyphenylamino)-1deoxyribulose-50-
phosphate (CdRP) is converted to indole 3-glycerol
phosphate [23]. PF3D7_1363700 protein alignment with
IGPS showed a 10.1% amino acid homology (specifically
5.0% identical amino acids) and no conserved catalytic
residues of IGPS, specifically, were present. Based on
these results, PF3D7_1363700 would not seem likely to
function as a metabolic enzyme involved in tryptophan
metabolism.
BLAST searches with PF3D7_1363700 in PlasmoDB
showed significant identity and similarity with a protein
in the human malaria parasites Plasmodium vivax
(PVX_115140 in PlasmoDB; 60.8%) and Plasmodium
knowlesi (PKH_110700 in PlasmoDB; 62.5%); avian mal-
aria parasite Plasmodium gallinaceum (Pg_c000129384.
Contig1-2-1079-2746 in PlasmoDB; 53%); rodent mala-
ria parasites Plasmodium berghei (PbANKA_113970 n
PlasmoDB; 60.3%), Plasmodium chabaudi (PCHAS_
113920 in PlasmoDB; 63%) and Plasmodium yoelii
(chrPyl_00226-5-31074-29071 in PlasmoDB; 61.6%) and
the non-human primate parasite Plasmodium reichenowi
(reich142b09.plk, reich382d09.qlk, reich915f08.plk, reich
838g12.plk in PlasmoDB; 81%) (Figure 1). In addition,
BLAST searches of EuPathDB demonstrated lower pro-
tein homology with other Apicomplexan proteins in
Toxoplasma gondii (15.4%); Neospora caninum (14.6%);
Theileria annulata (30%); and Babesia bovis (26%).
There were no orthologues in other higher eukaryotic
organisms suggesting that PF3D7_1363700 is unique to
Apicomplexans. In addition, the alignment of the
PF3D7_1363700 protein and its orthologues identified
a four-amino acid repeat sequence of aspartic acid, iso-
leucine, asparagine, and histidine (D-I-N-H), which
was found only in the PF3D7_1363700 orthologue in
P. falciparum.
PF3D7_1363700 Transcript is present in intra-erythrocytic
stage parasites, oocyst sporozoites and salivary gland
sporozoites
Mixed asexual blood stages, enriched gametocyte cultures,
day 8–10PEoocyst sporozoites, day 14–17PE salivary gland
sporozoites and axenic liver stages forPF3D7_1363700were
analysed for transcript expression. PF3D7_1363700 trans-
cripts were present throughout all the tested stages except
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producedintheabsenceoflivercellswereanalysedsincethere
was no success producing liver stages when using primary
humanhepatocytes.APfHsp70genecontrolwasusedtoshow
thepresence of liver stage parasites, whichwereproducedby
the axenic cultures. Stage-specific controls were used as a
positive control to demonstrate presence of parasites in all
experiments.
Previous transcript expression profile data for P.
falciparum were reported by Le Roch and colleagues who
used a high density oligonucleotide array to assess the
transcriptome of mosquito salivary gland sporozoite-,
ring-, trophozoite-, schizont-, merozoite- and gametocyte-
stage parasites [24]. Results from their whole genome wide
study showed transcript presence throughout all the stages
observed and complemented the higher accuracy RT-PCR
data generated in this single gene study, for mixed
erythrocytic stages, gametocytes and salivary gland
sporozoites. In addition, researchers analysed transcript
expression of activated sporozoites that were ready to
invade hepatocytes by incubating sporozoites for one
hour at 37°C with hepatocytes [25] and results showed
PF3D7_1363700 transcript to be upregulated in compari-
son to pre-activated salivary gland sporozoites. This re-Figure 2 PF3D7_1363700 transcripts are present in various stages of P
asexual blood stages, gametocytes, oocyst sporozoites, and salivary gland s
was produced from RNA isolated from mixed erythrocytic stages (ES), enric
axenic liver stages. PCR amplifications were performed using PF3D7_136370
merozoite surface protein 1 (MSP1) control primers for blood stage parasite
circumsporozoite (CS) primers for salivary gland and oocyst sporozoites and
stages. Plasmodium falciparum genomic DNA (gDNA) was used as a positiv
there was no genomic DNA contamination. DNA size markers in base pairssult would suggest that PF3D7_1363700 along with other
upregulated genes may prepare or help activate the sporo-
zoite for successful infection of the host tissue or
be necessary for early stages of hepatocyte infection.
PF3D7_1363700 transcript analysis in the oocyst spo-
rozoites and axenic liver stages has not been previously
reported in the literature and demonstrates new know-
ledge of transcript expression in these stages. Overall, a di-
verse transcript expression profile of PF3D7_1363700
demonstrated transcript presence in many parasite stages.
Analysis of PF3D7_1363700 protein presence in the intra-
erythrocytic stages
To assess the protein expression profile of PF3D7_1363700
during the intra-erythrocytic stages, P. falciparum asyn-
chronous intra-erythrocytic stage lysates were immu-
noblotted with anti-PF3D7_1363700 antibodies. ByWestern
blot analysis,PF3D7_1363700wasdetected inmixedP. falcip-
arum intra-erythrocytic parasites and enriched gametocyte
lysates, suggesting that the PF3D7_1363700 protein is pre-
sent during the erythrocytic stages (Figure 3). The band
representing PF3D7_1363700 appeared near the calculated
molecular mass of 92.8 kDa with the signal peptide and
89.1 kDa without its signal peptide. Anti-PF3D7_1363700lasmodium falciparum. PF3D7_1363700 transcripts are present in
porozoites as determined by reverse-transcription PCR (RT-PCR). cDNA
hed gametocytes, salivary gland sporozoites, oocyst sporozoites, and
0 specific primers and parasite control primers (+); P. falciparum
s, Pfs230 control primers for gametocytes, P. falciparum
P. falciparum heat shock protein 70 (PfHSP70) primers for axenic liver
e control while a no reverse transcriptase (−) reaction showed that
(bp) are shown to the right of the figure.
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(RBCs), while pre-immune control serumexhibited no cross-
reacting antibodies against intra-erythrocytic lysates, recom-
binantPF3D7_1363700-A,orRBCs.
To ascertain PF3D7_1363700 protein presence on a
single-cell level, immunofluorescent assays were per-
formed using anti-PF3D7_1363700 antibodies with
blood smears of mixed P. falciparum intra-erythrocytic
stages (i.e., rings, trophozoites, schizonts and game-
tocytes) and a mixture of stage I-V female and male
gametocytes. The PF3D7_1363700 protein was shown to
be present during the trophozoite, schizont and gameto-
cyte stages (Figure 4). Triplicate biological replicates of
approximately 100–300 stage-specific parasites/replicate
consistently showed PF3D7_1363700 expression with
an average percentage of PF3D7_1363700-expressing
parasites of 100% for trophozoite and schizont stages
and 57% for gametocyte stages mixed with stage I-V
gametocytes. There was no detection of PF3D7_1363-
700 protein during the ring stages, suggesting that
PF3D7_1363700 expression is time and stage-specific.
Using PfMSP-1 antibodies and Pfs230 control anti-
bodies, PF3D7_1363700 co-localized with the surface
protein PfMSP-1, albeit at a low resolution. Further
high-resolution studies are required in order to deter-
mine if PF3D7_1363700 is a surface protein or if it spe-
cifically localizes to other areas of the parasite.
In addition to IFA, a GFP-trafficking approach using the
endogenous PF3D7_1363700 promoter was performed to
investigate the presence of PF3D7_1363700 protein in the
mosquito and human host parasite stages. The 30-end of
PF3D7_1363700 was cloned in-frame with GFP in the
pPM2GT vector [16], yielding MpPM2GT. Following drug
selection for mutant parasites and limiting dilutions, a
clonal population (clone-81) was isolated and showed theFigure 3 PF3D7_1363700 protein is present during intra-
erythrocytic stages via Western blot analysis. PF3D7_1363700
protein was recognized by anti-PF3D7_1363700 antibodies in the P.
falciparum asynchronous asexual blood stages (ES) and enriched
gametocyte (G) lysates via Western blot analysis (as denoted by the
arrow). The pre-immune antibody did not detect this protein. The
recombinant PF3D7_1363700-A protein (rM) was used as a positive
control and non-infected RBCs (R) were used as a negative control.
Molecular weight markers in kilodaltons are shown to the left of
each figure. Three independent biological replicates were performed
and representative images are shown.presence of pPM2GT plasmid integration via PCR and
Southern blot analysis (Figure 5A-B). To assess if
MpPM2GT clone-81 parasites express PF3D7_1363700-
GFP protein during the intra-erythrocytic stages, anti-GFP
antibodies were used. Expression of the PF3D7_1363700-
GFP fusion protein was detected at ~110 kDa (Figure 5C).
In addition, MpPM2GT-Clone 81 was analysed on a
single-celled level and similar to the IFA results, green
fluorescence was detected in trophozoites and schizonts
while ring stages displayed minimal to no expression
(Figure 6). On the other hand, gametocyte stages, similar
in number and specific stages observed in IFA had no de-
tection of GFP fluorescence. This result could be
attributed to GFP expression having a lesser detection
signal than immunocytochemistry using Alexa-conjugated
secondary antibodies that gives a stronger signal [26]
and/or the possibility of PF3D7_1363700-GFP protein
being misfolded or processed differently than wild-type
PF3D7_1363700 protein [27]. These results were
confirmed by three independent biological replicates of
50–100 trophozoites/schizonts/gametocytes per replicate
in order to support the validity and reproducibility of
these results. Controls used for the GFP trafficking studies
were the negative control, P. falciparum NF54 wild-type
parasites, and as a positive control P. falciparum 3D7HT-
GFP which is a parasite line that constitutively expresses
the GFP protein in all parasite stages [9].
It has been reported in the literature that there is no
detection of the PF3D7_1363700 protein during the
intra-erythrocytic stages using high-accuracy mass
spectrometry [28,29]. While Lasonder and colleagues
analysed trophozoites, schizonts, gametocytes, and gametes
and Florens and colleagues observed merozoites, tro-
phozoites and gametocytes, both sets of authors did not
report the presence of the PF3D7_1363700 protein during
these observed stages. Lasonder and colleagues reported
that PfEMP1, a known asexual stage specific protein, sur-
prisingly did not exhibit high-scoring peptides, which they
stated could be due to poor extraction of the proteins [28].
Lasonder and colleagues also rejected low scoring proteins,
thereby suggesting that PF3D7_1363700 may not have
made the cut-off score and thus, was not considered signifi-
cant. Another explanation for the differences in results is
the type of technique used to assess protein expression.
The previous reported studies are based on a global profile,
large-scale mass spectrometry approach while the IFA and
GFP studies were performed on a specific, single-cell level
and Western blot analysis utilizes detection kits that are
sensitive enough to detect extremely low levels of protein.
In addition, both sets of authors synchronized the asexual
blood stages and collected these parasites at specific time
points, which may have prevented the analysis of proteins
expressed transiently before the collection time points, and
therefore they did not detect the PF3D7_1363700 protein.
Figure 4 PF3D7_1363700 protein appears to be present during late intra-erythrocytic stages as shown by immunolocalization studies using
confocal microscopy. Parasite-infected blood smears were triple-labelled with anti-PF3D7_1363700 polyclonal antibody (anti-PF3D7_1363700),
either anti-merozoite surface protein 1 (anti-PfMSP1) monoclonal antibody for asexual stages or anti-Pfs230 monoclonal antibody for gametocytes
(used as positive controls), and a nuclear stain, TO-PRO-3. Triplicate biological replicates of parasite-infected blood smears consistently show
PF3D7_1363700 expression during the trophozoite, schizont and gametocyte stages. Merged images with Differential Interference Contrast (DIC)
demonstrate protein co-localization with known surface proteins as shown by the yellow colour. Approximately 100–300 stage-specific parasites/
replicate were observed. The bottom panel of figures show the control pre-immune serum with minimal cross-reactivity in intra-erythrocytic
stage parasites (ES). Arrows denote the presence of parasites and representative images are shown with a scale bar, 5 μm.
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mosquito parasite stages
PF3D7_1363700 protein expression during the mosquito
parasite stages, which include zygotes, oocyst sporozoites,
haemolymph sporozoites and salivary gland sporozoites,
was also investigated via IFA and GFP trafficking stu-
dies. Anti-PF3D7_1363700 antibodies did not detect
PF3D7_1363700 protein in day 10 PE oocyst sporozoites
and salivary gland sporozoites of days 14, 15, 16, and 20
PE. To confirm results, two biological replicates of 100–
150 oocyst and salivary gland sporozoites were observed
using antibodies to the circumsporozoite (CS) protein and
pre-immune serum as a positive and negative control,respectively. Although one IFA biological replicate did de-
tect PF3D7_1363700 protein, this result was not reprodu-
cible. The possibility of the PF3D7_1363700 protein being
specifically expressed at different time points also was
addressed by observing sporozoites every day between
days 14 and 21 PE. However, there continued to be no de-
tectable protein.
In addition to the IFA results, GFP-trafficking studies
examined these same sporozoite stages as well as zygotes
and haemolymph sporozoites (Figure 6). Three independ-
ent biological replicates of the GFP studies also supported
that PF3D7_1363700 was undetectable during these para-
site stages in the mosquito. 3D7HT-GFP parasites were
Figure 5 A-C. Generation of PF3D7_1363700-GFP clonal populations that appear to express PF3D7_1363700-GFP during the intra-
erythrocytic stages. A stable integration event into the PF3D7_1363700 chromosomal locus was detected via genotype analyses. (A) For PCR
analysis, a genomic DNA template from wild-type parasites (WT) was used as a control and MpPM2GT transfected culture DNA before limiting
dilution (Preclonal) was used to demonstrate the presence of integrants and wild-type parasites carrying the episome. Clonal population
MpPM2GT-81 (81) was the experimental template. PCR primer combinations listed to the left of the figure were used to detect: 1) wild-type
parasites: gene specific forward and reverse (GSPF/R); 2) episomes: hDHFR F/R and 3) parasites with integration: gene specific forward (GSPF) and
GFP reverse (GFPR). The faint band that represents the detection of episome in wild-type control DNA was due to primers binding to DNA at a
temperature lower than the ideal annealing temperature. At ideal annealing temperatures, this band is not present. (B) For Southern blot analysis,
integration was detected by the presence of a 4.2-kb band while wild-type parasites with episome were represented by 2.7-kb and 5.1-kb bands.
The asterisk denotes an unknown band, which could be due to plasmid rearrangement after transfection. Genomic DNA from wild-type P.
falciparum NF54 parasites (WT) and transfected episome (P) were used as controls in the Southern blot experiments and a digoxigenin-labelled
PF3D7_1363700 DNA probe was used for detection. (C) PF3D7_1363700-GFP fusion protein (MGFP) from clonal population 81 appears to be
present using anti-GFP antibodies for detection as denoted by the arrow. Wild-type (WT) and 3D7HT-GFP (GFP+) parasites were used as negative
and positive controls, respectively, in the Western blot.
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Figure 6 PF3D7_1363700-GFP expression in various parasite stages. The PF3D7_1363700-GFP fusion protein of clonal population 81
(PfMGFP) was expressed only during the late asexual blood stages such as the trophozoites and schizonts. No expression was observed during
the ring stage (data not shown), gametocyte stage and mosquito parasite stages (i.e., zygote, oocyst sporozoite, haemolymph sporozoite (HS),
and salivary gland sporozoite (SGS). Expression of the fusion protein was under the control of the PF3D7_1363700 promoter. DAPI was used for
parasite nuclei staining. Orange arrowheads denote the presence of parasites in the merged images. 3D7GFP merge images depict constitutively
expressing parasites that were used as a positive control and –GFP merge are images of wild-type parasites that were used as a negative control.
Fluorescent images shown are representative of PF3D7_1363700 expression during that specific stage and three biological replicates were
performed for each stage observed.
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observed for all tested stages. Thus, PF3D7_1363700
was either expressed in undetectable amounts or not
expressed during these mosquito parasite stages. Previous
high-throughput mass spectrometry by Florens and
colleagues identified PF3D7_1363700 present in day 14PE
salivary gland sporozoites [29]; however the authors
detected a low specrum number of 1 for PF3D7_1363700in comparison to the significantly-expressed sporozoite
surface protein CS, which had a spectra number of 10.
This result along with IFA and GFP-trafficking data
reported herein would suggest that PF3D7_1363700 is
likely expressed at very low levels. In addition, there was
only one peptide match barely above the 95% confidence
level in a global proteomic expression analysis, suggesting
that PF3D7_1363700 protein presence during the salivary
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tion of this single correct peptide sequence in a
large mass of other proteins and any misidentification in
the peptide sequence would result in no detection of
PF3D7_1363700. Also, a cross-correlation score of 1.812
was exactly at the cut-off score for detectable proteins,
which also supports the low level detection of
PF3D7_1363700. Predictions of PF3D7_1363700 protein
being a secreted protein could also be a reason why the
protein was difficult to detect, especially if the protein was
secreted from the sporozoite and released in the
mosquito.Multiple attempts at isolating PF3D7_1363700-disrupted
mutant parasites were not successful
To assess the role of PF3D7_1363700 during the late
intra-erythrocytic stages, a classical single-crossover gene
disruption of PF3D7_1363700 was performed. In order to
disrupt PF3D7_1363700, 441 or 710 bp of the 50-end of
PF3D7_1363700 was cloned into pCAM-BSD [30] (i.e.,
designated M441pCAM and M710pCAM), which utilizes
the blasticidin S deaminase (BSD) drug cassette and then
transfected into P. falciparum NF54 parasites. The geno-
type of drug-resistant parasites was analysed after each
round of drug selection via PCR analysis and it was
discovered that M441pCAM and M710pCAM parasites
displayed evidence of an integration event; however wild-
type parasites with the episome were also present.
After this observation, multiple attempts were made to
isolate a clonal population of the PF3D7_1363700-
disrupted parasites via limiting dilutions. However after
PCR analysis, each potential clonal population always had
wild-type parasites with episome present. For M441pCAM
genotype analyses, seven populations out of 784 wells had
both parasites with integration and wild-type parasites with
episome and M710pCAM genotype analyses resulted in
four populations out of 392 wells that were also mixed with
integrants and wild-type parasites with episomes. There-
fore, no population with only parasites with integration was
detected. The inability to separate the integrants from wild-
type parasites with the episome could be the result of wild-
type parasites with the replicating episome outgrowing the
integrants [31,32]. Hence, the PF3D7_1363700 gene may be
needed for parasite growth or survival. Some Plasmodium
intra-erythrocytic stage proteins that are essential for para-
site survival, such as apical membrane associated protein
(AMA-1), falcipain-3 (FP3), calpain, and merozoite surface
protein (MSP-119) genes, have resulted in failed disruption
and deletion attempts due to the lethal nature of the gene
manipulation [33-37]. Therefore, the failed attempts to ob-
tain a PF3D7_1363700-disrupted clonal population would
support a potential role of PF3D7_1363700 that is critical
to the parasite.Conclusions
Identifying and characterizing gene candidates involved
in host-parasite interactions, development, and metabol-
ism throughout the entire life cycle of P. falciparum is a
major asset to understanding the overall biology of mal-
aria parasites and discovering interesting candidates for
vaccine/drug intervention. This research addresses a once
uncharacterized Plasmodium gene, PF3D7_1363700, which
was identifiedbydataminingofPlasmoDB.PF3D7_1363700
has an N-terminal signal sequence, is predicted to be a
secreted protein, and is a well-conserved protein in many
Plasmodium species. The transcript expression profile of
PF3D7_1363700obtainedviaRT-PCRandcomplementedby
DNAmicro-array studiesdescribed in the literature, demon-
strated transcript presence in oocyst and salivary gland
sporozoites of the mosquito host and intra-erythrocytic
stages of the human host [24,25]. Although initial screening
viaPlasmoDBcharacterizedPF3D7_1363700asa sporozoite
protein, the current study demonstrates PF3D7_1363700
protein expression only during the late intra-erythrocytic
stages.Functionalstudieswereattemptedtoidentifyaspecific
roleofPF3D7_1363700;howeveritwasnotpossible toisolate
a PF3D7_1363700-disrupted clonal population because
wild-type parasites with the episome were always present.
Since some previously studied intra-erythrocytic stage
proteins cannot be disrupted or deleted, it has led to the
possibility that these genes may be essential for parasite
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